chrisvoncsefalvay/vaers-outcomes huggingface dataset:
pain after first dose for one day; This spontaneous case was reported by a patient and describes the occurrence of PAIN (pain after first dose for one day) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011AZ1A) for COVID-19 vaccination.     Patient did not had any any allergy and never had covid positive test or diagnosis.  Concurrent medical conditions included Diabetes (25 year ago) and Blood pressure high. Concomitant products included INSULIN GLARGINE (TOUJEO) for an unknown indication.  On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In March 2021, the patient experienced PAIN (pain after first dose for one day). In March 2021, PAIN (pain after first dose for one day) had resolved.      mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.   No treatment medications was provided by the reporter.   This case was linked to MOD-2022-570141 (Patient Link).
I have migraine its been 24 hours since my 2nd vaccine; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (I have migraine its been 24 hours since my 2nd vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Migraine.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MIGRAINE (I have migraine its been 24 hours since my 2nd vaccine). At the time of the report, MIGRAINE (I have migraine its been 24 hours since my 2nd vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment medications were reported.
Pt called and stated that after she had a lot of pain in the arm that the PNEUMOVAX was administered. Pt will go see Dr and also will take Naproxen.
Systemic: Fainting / Unresponsive-Mild, Systemic: Hypotension-Mild, Systemic: Shakiness-Mild, Additional Details: patient had episode of syncope, fainted for about 10 seconds after receiving vaccine. we kept him down on floor until he felt well enough to sit up.  took BP and HR, initial reading 89/62 HR 75... instructed patient to keep head down and try to relax, also gave patient water. took BP and HR again 10 minutes later, BP 107/69 and HR 77... patient remained in store for 30 minutes total then felt well enough to leave.  contacted patient 8/5 and patient said he is feeling much better and doing fine
Inadvertently received Pediarix (DTaP-IPV-HBV) vaccine instead of DTaP.  Also received IPV and MMR vaccines at the same time on 12-19-2007.  E-mailed NIPINFO for guidance informed to complete VAERS report, take steps to ensure that mistake does not happen again and that no intervention is needed for the child. There was no adverse event.
Headache, Myalgia,& Tachycardia Narrative: Tachycardia, circumoral tingling. Headache, body aches, the following day.
Patient c/o slight headache and lightheaded at 0415 pm no other sx, denied abdominal pain, nausea vomiting, shortness of breath, chest pain, wheezing, rash. no documented allergies in past but thinks he might have had allergies to one of the antibiotics in past not sure of the name.  VS done at 0415: BP: 145/82 HR: 73 sats:98%  VS done at 0430: BP:134/83 HR: 78 sats : 98% on RA. Pt remained stable and was monitored until 0446 and patient left in stable condition this case of consulted with physician present at the time of event Patient was given ER precautions to go to ER if any new sx start or current sx get worse.
Client had vaccines 7/16/2009.  Reports that at 11:30 this am (7/17/09) she started with lower facial tingling and family member says that when the client spoke her lips and lower side of face appeared to be pushed to the right side. Denies any weakness but smile does appear to be lopsided when client returned to clinic today at 3:30 pm. Denies any additional symptoms. Referred to primary doctor and left center at 3:45 pm to see doctor. (Family member made appt. while in office at center 7/17/09 ) Doctor contacted family for follow-up. Stated that family took pt to doctor on 7/17 and was diagnosed with Bells Palsy.
Brain fog and confusion 24 hours after 2nd dose; Brain fog and confusion 24 hours after 2nd dose; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 39 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 04Jun2021 17:30 (Lot number: EW0217) at the age of 39 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: Bnt162b2 (First dose), for Covid-19 Immunization. The following information was reported: FEELING ABNORMAL (non-serious), CONFUSIONAL STATE (non-serious) all with onset 05Jun2021 10:00, outcome "recovering" and all described as "Brain fog and confusion 24 hours after 2nd dose". Therapeutic measures were not taken as a result of feeling abnormal, confusional state.  Additional information: No other vaccine in four weeks. No other medications in two weeks. No covid prior vaccination. No covid tested post vaccination. No known allergies and no other medical history.  Follow-up attempts are completed. No further information is expected.
Parent/guardian lied about the age of the child in order to get the child vaccinated against COVID-19.
Sore Breasts; heavy, painful menstruation; heavy, painful menstruation; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 39 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 24Aug2021 20:00 (Lot number: fe 3183) at the age of 39 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "PCOS" (unspecified if ongoing), notes: other medical history: PCOS, Endometriosis; "Endometriosis" (unspecified if ongoing), notes: other medical history: PCOS, Endometriosis; "Latex" (unspecified if ongoing), notes: known allergies: Latex, coconut; "coconut" (unspecified if ongoing), notes: known allergies: Latex, coconut. There were no concomitant medications. The following information was reported: BREAST PAIN (non-serious) with onset 26Aug2021, outcome "unknown", described as "Sore Breasts"; HEAVY MENSTRUAL BLEEDING (non-serious), DYSMENORRHOEA (non-serious) all with onset 26Aug2021, outcome "unknown" and all described as "heavy, painful menstruation". Therapeutic measures were not taken as a result of breast pain, heavy menstrual bleeding, dysmenorrhoea. No follow-up attempts are possible. No further information is expected.
This spontaneous report as received from a pharmacist refers to an unspecified patient of unknown age. The patient was inadvertently administered VARIVAX (1 dose from vial, Subcutaneous, lot # not reported) instead of ZOSTAVAX on 29-AUG-2012. No adverse effect reported. No other co-suspects were reported. No concomitant medications were reported. At the report time the outcome of event was unknown. It was unknown if the patient sought medical attention. Additional information is not expected.
Got extremely cold and shivering starting around 6:30 pm on Friday 3/12/21.  Could not get warm.  Took my temperature and it was 97.1 (my temp is usually in the mid 97's).  Weak and tired.  Took Tylenol about 7:30 pm - it helped a little but still felt freezing cold.  Went to bed and next morning felt better but wrung out.
07/02/2022 I was supposed to go to friend?s house and was feeling ill. I took a test it was negative, and I thought it was just allergies. I went to  Cough, nasal congestion, and slight fever  07/03/2022 I went to urgent care, and I was positive, and the doctor gave me the antiviral.  I isolated for more than 15 days I had recovered on July 9th.
Patient presented 1/9/07 with right arm red and swollen. Swelling was progressing outward from injection site. Patient received Dtap, IPOL and Hepatitis A ON 1/8/07. Amoxicillin prescribed.
Patient states that the nurse injected too high into her shoulder joint.  This caused numbness and pain.
BABY SPIKED A 104.7 TEMP POST VACCINATION ON THE EVENING OF 9/26/16.
Pt had flu vaccine on 1-23-09. Since that date until present date pt c/o pain in rt deltoid area- no swelling, edema or temperature noted.
I had an onset of extreme vertigo (BPPV) that has lasted for approximately 4 weeks.
Chills on 5/29/14, followed by "throat closing" and swollen lymph nodes in left supraclavicular region from 5/30/14 through 6/2/14 -- tender lymph node palpated by me.  Reports Tmax 99.2 with accompanying rash.  Prior tetanus history 2002 was Td.
DOSE 1 12/20/2021, began to feel sick. 12/24/2021 I had a high fever, called the CDC, a physician spoke with me, then on Christmas day I called into work sick, I went to ER, and I tested positive for COVID. DOSE 2 01/07/2021, I had shortness of breath, high heart rate, fatigue, brain fog, body aches, some coughing, some nasal congestion. Testing on Feb 1st, 2021 visited ER.
Left arm extremely painful, pain traveling to wrist and hand. Recommended contact dr at clinic. No temperature.
12 yo female with significant local reaction 9x15 cm with erythema, pain, and hot.
This spontaneous report as received from a medical assistant refers to multiple unspecified patients of an unknown age and gender. The patient's concurrent conditions, medical history and concomitant therapy were not reported. On unknown dates, the patients were vaccinated with an unspecified number of doses of improperly stored ROTATEQ orally, lot # L013204, expiration date: 28-JAN-2017 (dose was not reported). The vaccines were stored at 1 degree Celsius within 23 hours. There was no previous temperature excursion. There were no adverse effects reported. Product quality complaint was not involved. This is one of several reports received from the same reporter. Additional information has been requested.
Information has been received from a registered nurse concerning a patient at an elementary school who was vaccinated with a dose of varicella virus vaccine live (Oka/Merck). Subsequently, the patient developed a mild case of breakthrough varicella. There was no product quality complaint involved. Additional information has been requested.
Flu like symptoms; Left arm pit lump; Right hip pain; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 33 year-old patient received bnt162b2 (BNT162B2), administered in arm left, administration date 30Jul2021 17:00 (Lot number: EW0180) at the age of 33 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Polycystic ovary syndrome" (ongoing), notes: Polycystic ovary syndrome PCOS, Onset date:10+years; "Prediabetic" (ongoing), notes: Onset date:3+years. The patient's concomitant medications were not reported. The following information was reported: INFLUENZA LIKE ILLNESS (non-serious) with onset 31Jul2021, outcome "recovered" (02Aug2021), described as "Flu like symptoms"; AXILLARY MASS (non-serious) with onset 2021, outcome "recovered" (03Aug2021), described as "Left arm pit lump"; ARTHRALGIA (non-serious) with onset 2021, outcome "recovered" (24Aug2021), described as "Right hip pain". Therapeutic measures were taken as a result of influenza like illness, axillary mass, arthralgia.  Additional Information: Vaccination Facility type was Pharmacy or Drug Store. The patient received tylonal as treatment for flulike symptoms, left arm pit lump and right hip pain.  Follow-up attempts are completed. No further information is expected.
Initially right deltoid area redness and swelling, and progressed to a cellulitis and associated right axillary adenitis. Required oral antibiotics.
No additional adverse effect reported; Caller reported that VAQTA and ROTATEQ that underwent temperature excursions; This spontaneous report was received from a physician and refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided.  On 11-NOV-2021, the patient was vaccinated with improperly stored dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) administered orally, lot # 1821791, expiration date 26-JUL-2022 (dose and anatomical location were not reported) for prophylaxis. Administered dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) experienced temperature excursion of 0.7 degrees Celsius for 2 hours. There was no previous excursion reported. No additional adverse event was reported.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2112USA000823: US-009507513-2112USA000818: US-009507513-2112USA000824: US-009507513-2112USA000713: US-009507513-2112USA000822: US-009507513-2112USA000820: US-009507513-2112USA000817: US-009507513-2112USA000819: US-009507513-2112USA000821:
Chief Complaints: Progressive weakness  with respiratory difficulty and severe shortness of breath  Diagnosis: Guillain-Barre supported by progressive weakness, albumincytologic dissociation of cerebral spinal fluid, vocal cord paralysis, speech apraxia resulting in aspiration pneumonia   Treatment: Guilain-Barre: Plasmapheresis  requiring critical care management  Pneumonia: Antibiotics
This spontaneous report as received from a healthcare worker (who is also the patient's mother) refers to a 12 year old male patient. On 03-OCT-2013 the patient was vaccinated with GARDASIL (lot # J007354) dose, route not reported. No other co suspects were reported. No concomitant therapy was reported. The reporter stated that the patient experienced soreness at the injection site "about 8 to 12 hours" after the administration. The reporter stated that the soreness went away with about 24 to 48  hours later. Treatment was not given for the event. The patient did not seek medical attention. The reporter stated that an unspecified number of patients received doses of GARDASIL from recalled lot on unspecified dates. No adverse effect reported for any unspecified patients. The outcome of the patient experienced soreness at the injection site was reported as recovered/resolved. Additional information is not expected.
Patient had fainting spell turning cold and sweating with B/P 60/40. Patient had been putting on sitting position and then staff lied him down on the treatment bed. After 15 min., patient felt better without any medication.
fatigue and dyspnea, onset several days after injection, progressed over several weeks to months, found to have pulmonary embolism on 7/7/2021
Pt developed swelling, slight hematoma, high fever of 102F and tenderness to right upper deltoid area at DTAP, 24 hours, post vax. Treated with Tylenol and Hydrocortisone creme. Swelling subsided a few hours afterwards. Seen on 9/19/01 and fever like-wise went down.
12/26/21 presents to  ED for "dyspnea". PMHx of "HTN, HLD, AS s/p bioprosthetic replacement"
Pt received vaccine on 5/10/16. Began swelling, tenderness and redness to next day. It is very itchy. She knows to use ice, TYLENOL and topical BENADRYL if needed for itch. The reaction lasted 6 days.
Moderna booster was administered to patient after manufacturer provided expiration date.  No adverse reactions reported by the patient.  Moderna notified and is performing a lot assessment to determine activity level of the vaccine on date of administration.
Approximately 24 hours after injection area a rash developed and grew to small palm size, is warm and firm to the touch.  It also itches occasionally.   Other than being aware of the rash,  it seems insignificant.   It is now 48 hours since injection.
This case was reported by a other health professional via call center representative and described the occurrence of extensive swelling of vaccinated limb in a 63-year-old female patient who received SHINGRIX for prophylaxis. On 1st October 2018, the patient received SHINGRIX .5 ml. In October 2018, less than a week after receiving SHINGRIX, the patient experienced extensive swelling of vaccinated limb and injection site warmth. On an unknown date, the outcome of the extensive swelling of vaccinated limb and injection site warmth were unknown. It was unknown if the reporter considered the extensive swelling of vaccinated limb and injection site warmth to be related to SHINGRIX. Additional details were provided as follows: The patient received SHINGRIX on right deltoid. After receiving SHINGRIX, the patient experienced large swelling at injection site that went up to the patient's clavicle and it was warm to touch. This case has been linked with the case US2018182677, reported by same reporter.
Patient became light headed and passed out around 15 seconds post vaccination.  After placing his head between his knees, he woke up.  Escorted by emergency personal to ambulance.
Patient was running a fever just under 101 F and having dry heaves and nausea.
I tested positive for COVID-19 6/23/22 at 9pm . My first symptom was a sore throat. The sore throat persisted through Friday accompanied by a mild headache. However, on Saturday and Sunday my symptoms escalated from mild: I felt very sick and experienced coughing, sneezing, headache, fatigue, body aches, dizziness, a was very congested which didn't respond to cold medicines.  Each day I felt worse and on Monday contacted my doctor to get started on Paxlovid which I started 6/27/22 at 8pm.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 69-year-old male patient received BNT162b2 (BNT162B2), on 24Feb2021 at 16:45 as dose 1, single (Batch/Lot number: unknown), in left arm, on 26Mar2021 at 17:15 as dose 2, single (Batch/Lot number: unknown), in left arm and on 01Nov2021 at 14:30 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 69 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Diabetes" (unspecified if ongoing), notes: other medical history: Diabetes; "known allergies: sulpher drugs" (unspecified if ongoing), notes: known allergies: sulpher drugs. There were no concomitant medications. The following information was reported: VACCINATION FAILURE (medically significant), SUSPECTED COVID-19 (medically significant) all with onset 2022, outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of vaccination failure, suspected covid-19. Patient received treatment for the event COVID-19 as Paxlovid (Lot number: FY4445) from 25Apr2022 to 30Apr2022. The patient was not taking any other medications/products within 2 weeks of starting COVID-19 treatment. After the first 2 doses of Paxlovid developed a metalic/chalk like taste in my mouth from 25Apr2022 at 06:45 pm. Patient did not received treatment for this event.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Felt faint, dizzy, heart palpitations within 30 min following inj. Lasted x 4 hr. Did not need treatment.
Patient receive the booster (0.25ml) instead of the first dose; This spontaneous case was reported by a nurse and describes the occurrence of ACCIDENTAL UNDERDOSE (Patient receive the booster (0.25ml) instead of the first dose) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018F21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On an unknown date, the patient experienced ACCIDENTAL UNDERDOSE (Patient receive the booster (0.25ml) instead of the first dose). At the time of the report, ACCIDENTAL UNDERDOSE (Patient receive the booster (0.25ml) instead of the first dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
twitching of arms & hands noted by sister while waiting for mom to pay for inject; walked from treatment room to pt-color pale, skin cool & moist, unresponsive to verbal stimuli, pulse thin, no resp until placed on floor then began crying;
Fever Chills Body aches Headache Axilla swollen and sore Site injection soreness
under her arm hurts and she has swelling in her armpit; under her arm hurts and she has swelling in her armpit; injection site pain; This is a spontaneous report from a contactable Nurse reported for herself.   A 65-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), on 23Jan2021 around 10 a.m. at single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. Before she went to the appointment, she stated that she took ibuprofen without knowing it was not recommended. Then around 8 of the day of the vaccination she took more ibuprofen because she was experiencing injection site pain. Caller stated that under her arm hurts and she has swelling in her armpit. The outcome of the events was unknown.   Information on the lot/batch number has been requested.
8:00 pm Wednesday rash (welted hives) appeared on chest, stomach and upper arms. Thursday morning it had spread to upper thighs and both arms. 9:30 am doctor appointment was prescribed a Methylprednisone taper. Extreme fatigue occurred at 1:30 pm, took 3 steroid pills and slept until 5:15 pm. Woke up to find rash had spread to back and buttocks and palms. Also developed trouble breathing with cough and throat clearing. Went to urgent care. Given a shot of benadryl and Methylprednisone in left and right buttocks respectively. Rash started to go down. Was sent home with a new regimen of benadryl, prednisone, and pepsid. Did not take anymore of the Methylprednisone taper. Went to sleep at 9:30 and woke at 3:30 for more meds. Rash had spread again to face, ears, and neck. Went to er. Given two benadryl and 1 pepsid and a prescription for epipen and sent home. Went to primary care physician at 9:45 for unrelated toenail fungus that started a year ago and has not healeded. Went home and slept until 1:30. Woke up to rash having spread again to legs  (it covered face, neck, ears, hands, palms, arms, chest, stomach, back, buttocks, genitals, and upper legs now). Went to a dermatologist who stated it could be the Moderna but since it had started 6 days after the shot we can't be sure one way or the other. Given new prednisone regimen with levocetirizine and hydroxyzine. Stopped other medications. Went to bed at 9:30 and woke throughout the night due to burning/itching and chills. 9:30 am rash now covers body from scalp to soles of feet.